Home/Pipeline/BioTraceIO Vision

BioTraceIO Vision

Liver and kidney tumor ablation

FDA‑clearedActive

Key Facts

Indication
Liver and kidney tumor ablation
Phase
FDA‑cleared
Status
Active
Company

About TechsoMed

AI‑powered software that makes minimally invasive tumor ablation precise, reproducible, and curative.

View full company profile

Therapeutic Areas

Other Liver and kidney tumor ablation Drugs

DrugCompanyPhase
BioTraceIO PrecisionTechsoMedFDA‑cleared